• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利巴韦林和霉酚酸增强鸟嘌呤和二氨基嘌呤类核苷类似物对乙型肝炎病毒的活性。

Ribavirin and mycophenolic acid potentiate the activity of guanine- and diaminopurine-based nucleoside analogues against hepatitis B virus.

作者信息

Ying C, De Clercq E, Neyts J

机构信息

Rega Institute for Medical Research, K.U. Leuven, Minderbroedersstraat 10, B-3000, Leuven, Belgium.

出版信息

Antiviral Res. 2000 Nov;48(2):117-24. doi: 10.1016/s0166-3542(00)00121-2.

DOI:10.1016/s0166-3542(00)00121-2
PMID:11114413
Abstract

Mycophenolic acid [the active metabolite of the immunosuppressive agent mycophenolate mofetil (MMF)] and ribavirin were found to potentiate the anti-HBV activity of the guanine-based nucleoside analogues penciclovir (PCV), lobucavir (LBV) and 3'-fluorodideoxyguanosine (FLG) and diaminopurine dioxolane (DAPD). Ribavirin and mycophenolic acid are both inhibitors of inosine 5'-monophosphate dehydrogenase and cause a depletion of intracellular dGTP levels. It may be assumed that the 5'-triphosphorylated derivatives of the guanine-based nucleoside analogues, in the presence of reduced levels of dGTP, inhibit more efficiently the priming reaction as well as the reverse transcription and DNA-dependent DNA polymerase activity of the HBV polymerase. This assumption is corroborated by the observation that exogenously added guanosine reversed the potentiating effect of ribavirin and mycophenolic acid on the anti-HBV activity of the guanosine analogues. Our observations may have implications for those (liver) transplant recipients that receive MMF as (part of their) immunosuppressive regimen and that, because of de novo or persistent infection with HBV, need specific anti-HBV therapy.

摘要

霉酚酸[免疫抑制剂霉酚酸酯(MMF)的活性代谢产物]和利巴韦林被发现可增强鸟嘌呤核苷类似物喷昔洛韦(PCV)、洛布卡韦(LBV)、3'-氟脱氧鸟苷(FLG)和二氨基嘌呤二氧戊环(DAPD)的抗乙肝病毒活性。利巴韦林和霉酚酸都是肌苷5'-单磷酸脱氢酶的抑制剂,可导致细胞内dGTP水平降低。可以推测,在dGTP水平降低的情况下,鸟嘌呤核苷类似物的5'-三磷酸化衍生物能更有效地抑制引发反应以及乙肝病毒聚合酶的逆转录和依赖DNA的DNA聚合酶活性。这一推测得到了以下观察结果的确证:外源性添加鸟苷可逆转利巴韦林和霉酚酸对鸟苷类似物抗乙肝病毒活性的增强作用。我们的观察结果可能对那些接受MMF作为免疫抑制方案(一部分)的(肝脏)移植受者有影响,这些受者因新发或持续性乙肝病毒感染而需要特异性抗乙肝病毒治疗。

相似文献

1
Ribavirin and mycophenolic acid potentiate the activity of guanine- and diaminopurine-based nucleoside analogues against hepatitis B virus.利巴韦林和霉酚酸增强鸟嘌呤和二氨基嘌呤类核苷类似物对乙型肝炎病毒的活性。
Antiviral Res. 2000 Nov;48(2):117-24. doi: 10.1016/s0166-3542(00)00121-2.
2
Ribavirin and mycophenolic acid markedly potentiate the anti-hepatitis B virus activity of entecavir.
Antiviral Res. 2007 Mar;73(3):192-6. doi: 10.1016/j.antiviral.2006.10.003. Epub 2006 Oct 30.
3
In vitro combination of amdoxovir and the inosine monophosphate dehydrogenase inhibitors mycophenolic acid and ribavirin demonstrates potent activity against wild-type and drug-resistant variants of human immunodeficiency virus type 1.体外实验中,氨多索韦与肌苷单磷酸脱氢酶抑制剂霉酚酸和利巴韦林联合使用,对1型人类免疫缺陷病毒的野生型和耐药变异株均显示出强大的活性。
Antimicrob Agents Chemother. 2004 Nov;48(11):4387-94. doi: 10.1128/AAC.48.11.4387-4394.2004.
4
Inhibition of the replication of the DNA polymerase M550V mutation variant of human hepatitis B virus by adefovir, tenofovir, L-FMAU, DAPD, penciclovir and lobucavir.阿德福韦、替诺福韦、L-FMAU、DAPD、喷昔洛韦和洛布卡韦对人乙型肝炎病毒DNA聚合酶M550V突变变体复制的抑制作用。
J Viral Hepat. 2000 Mar;7(2):161-5. doi: 10.1046/j.1365-2893.2000.00210.x.
5
The immunosuppressive agent mycophenolate mofetil markedly potentiates the activity of lobucavir [1R(1alpha,2beta,3alpha)]-9-[2,3-bis(hydroxymethyl)cyclobutyl]guanine against different herpes viruses.免疫抑制剂霉酚酸酯可显著增强洛布卡韦[1R(1α,2β,3α)]-9-[2,3-双(羟甲基)环丁基]鸟嘌呤对不同疱疹病毒的活性。
Transplantation. 1999 Mar 15;67(5):760-4. doi: 10.1097/00007890-199903150-00022.
6
The antiherpesvirus activity of H2G [(R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine] is markedly enhanced by the novel immunosuppressive agent mycophenolate mofetil.新型免疫抑制剂霉酚酸酯可显著增强H2G[(R)-9-[4-羟基-2-(羟甲基)丁基]鸟嘌呤]的抗疱疹病毒活性。
Antimicrob Agents Chemother. 1998 Dec;42(12):3285-9. doi: 10.1128/AAC.42.12.3285.
7
Mycophenolic acid, an immunosuppressive agent, inhibits HBV replication in vitro.霉酚酸是一种免疫抑制剂,在体外可抑制乙肝病毒复制。
J Viral Hepat. 1999 May;6(3):229-36. doi: 10.1046/j.1365-2893.1999.00163.x.
8
Inhibitions of human parainfluenza virus type 2 replication by ribavirin and mycophenolate mofetil are restored by guanosine and S-(4-nitrobenzyl)-6-thioinosine.利巴韦林和霉酚酸酯对人副流感病毒2型复制的抑制作用可被鸟苷和S-(4-硝基苄基)-6-硫代肌苷恢复。
Drug Discov Ther. 2019;13(6):314-321. doi: 10.5582/ddt.2019.01084.
9
The anti-herpesvirus activity of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl)-cycloprop-1'-yl]methyl]guanine is markedly potentiated by the immunosuppressive agent mycophenolate mofetil.免疫抑制剂霉酚酸酯可显著增强(1'S,2'R)-9-[[1',2'-双(羟甲基)-环丙-1'-基]甲基]鸟嘌呤的抗疱疹病毒活性。
Antiviral Res. 2001 Feb;49(2):121-7. doi: 10.1016/s0166-3542(00)00145-5.
10
Inhibition of hepatitis B virus DNA polymerase by enantiomers of penciclovir triphosphate and metabolic basis for selective inhibition of HBV replication by penciclovir.喷昔洛韦三磷酸酯对映体对乙型肝炎病毒DNA聚合酶的抑制作用及喷昔洛韦选择性抑制乙肝病毒复制的代谢基础
Hepatology. 1996 Nov;24(5):996-1002. doi: 10.1002/hep.510240504.

引用本文的文献

1
The Combination of GS-441524 (Remdesivir) and Ribavirin Results in a Potent Antiviral Effect Against Human Parainfluenza Virus 3 Infection in Human Airway Epithelial Cell Cultures and in a Mouse Infection Model.GS-441524(瑞德西韦)与利巴韦林联合使用对人呼吸道上皮细胞培养物中的人副流感病毒3感染以及小鼠感染模型具有强效抗病毒作用。
Viruses. 2025 Jan 26;17(2):172. doi: 10.3390/v17020172.
2
What role for cellular metabolism in the control of hepatitis viruses?细胞代谢在肝炎病毒控制中的作用是什么?
Front Immunol. 2022 Nov 17;13:1033314. doi: 10.3389/fimmu.2022.1033314. eCollection 2022.
3
Inhibitors of Nucleotide Biosynthesis as Candidates for a Wide Spectrum of Antiviral Chemotherapy.
作为广谱抗病毒化疗候选药物的核苷酸生物合成抑制剂
Microorganisms. 2022 Aug 12;10(8):1631. doi: 10.3390/microorganisms10081631.
4
Strategy, Progress, and Challenges of Drug Repurposing for Efficient Antiviral Discovery.用于高效抗病毒药物发现的药物重新利用策略、进展与挑战
Front Pharmacol. 2021 May 4;12:660710. doi: 10.3389/fphar.2021.660710. eCollection 2021.
5
Investigational drugs with dual activity against HBV and HIV (Review).对乙肝病毒和艾滋病毒具有双重活性的研究性药物(综述)
Exp Ther Med. 2021 Jan;21(1):35. doi: 10.3892/etm.2020.9467. Epub 2020 Nov 11.
6
The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19.抗风湿药物的抗病毒作用:COVID-19 带来的启示。
J Autoimmun. 2020 Jul;111:102468. doi: 10.1016/j.jaut.2020.102468. Epub 2020 Apr 17.
7
Reactivation of hepatitis B virus infection in rheumatic diseases: risk and management considerations.风湿性疾病中乙型肝炎病毒感染的再激活:风险及管理考量
Ther Adv Musculoskelet Dis. 2020 Mar 16;12:1759720X20912646. doi: 10.1177/1759720X20912646. eCollection 2020.
8
Hepatitis B recurrence after liver transplantation: a single center experiences and review the literature.肝移植后乙肝复发:单中心经验及文献综述
Hepat Mon. 2013 Jan;13(1):e6609. doi: 10.5812/hepatmon.6609. Epub 2013 Jan 1.
9
Prevention of hepatitis C recurrence after liver transplantation: An update.肝移植后丙型肝炎复发的预防:最新进展
World J Gastrointest Pharmacol Ther. 2012 Aug 6;3(4):36-48. doi: 10.4292/wjgpt.v3.i4.36.
10
Exploiting the anti-HIV-1 activity of acyclovir: suppression of primary and drug-resistant HIV isolates and potentiation of the activity by ribavirin.利用阿昔洛韦的抗 HIV-1 活性:抑制原发性和耐药性 HIV 分离株,并通过利巴韦林增强其活性。
Antimicrob Agents Chemother. 2012 May;56(5):2604-11. doi: 10.1128/AAC.05986-11. Epub 2012 Feb 6.